Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPondyloArthritis: Inducing Drug-free Remission by Early TNF-Alpha bloCkade Under Guidance of Single Cell RNA Sequencing and Epigenetic Profiling. (The SPARTACUS Trial)

NCT04435288 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT04435288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPondyloArthritis: Inducing Drug-free Remission by Early TNF-Alpha bloCkade Under Guidance of Single Cell RNA Sequencing and Epigenetic Profiling. (The SPARTACUS Trial)
Lead sponsor
University Hospital, Ghent
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 24, 2020
Completion date
December 31, 2028
Enrollment
90 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral spondyloarthritis